Mazzarotto, Francesco http://orcid.org/0000-0002-6159-9980
Argirò, Alessia
Zampieri, Mattia
Magri, Chiara http://orcid.org/0000-0001-9933-8666
Giotti, Irene
Boschi, Beatrice
Frusconi, Sabrina
Gennarelli, Massimo
Buxbaum, Joel
Polimanti, Renato http://orcid.org/0000-0003-0745-6046
Olivotto, Iacopo
Perfetto, Federico
Cappelli, Francesco
Funding for this research was provided by:
Pfizer Inc. (Pfizer Italy) supported this work with an unconditional research grant given to the Tuscan Regional Amyloidosis Centre, Florence, Italy.
Article History
Received: 18 August 2022
Revised: 20 October 2022
Accepted: 2 November 2022
First Online: 15 November 2022
Competing interests
: The authors declare no competing interests.
: All participants gave written informed consent and the study was approved by the local ethics committee (reference number: CEAVC 16021).